Staying on TRK: Addressing Clinical Challenges and Improving Outcomes in NTRK Fusion–Positive Cancers

Download these expert-selected slides with the latest information on testing for TRK fusions and treating your patients with NTRK fusion-positive cancers.
George D. Demetri, MD
Alexander Drilon, MD
Theodore Laetsch, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.24 MB
Released: June 16, 2021


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Genentech, a member of the Roche Group

Related Content

Clinical Care Options (CCO) commentary: Joel Neal, MD, discusses management of non-small-cell lung cancer (NSCLC) with uncommon EGFR mutations

Joel W. Neal, MD, PhD Released: May 20, 2022

Interactive expert-led video on targeted therapies for glioblastoma, from Clinical Care Options (CCO)

Andrew B. Lassman, MD
Program Director
Timothy Cloughesy, MD Rimas V. Lukas, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: May 19, 2022 Expired: May 18, 2023

On-demand webcast on biomarker-driven care for patients with NSCLC, from Clinical Care Options (CCO)

Todd M. Bauer, MD Sandip P. Patel, MD Joshua Sabari, MD Physicians: maximum of 1.75 AMA PRA Category 1 Credits Released: May 12, 2022 Expired: May 11, 2023

Downloadable slides for oncologists, pharmacists, and nurses: Immunotherapy and chemotherapy for extensive-stage SCLC from Clinical Care Options (CCO)

Released: May 11, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings